Navigation Links
TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Date:9/5/2007

evaluated the performance of the TAXUS paclitaxel-eluting stent (PES) compared to a bare-metal stent (BMS) control in patients with coronary artery disease. The TAXUS WOMAN study analyzed pooled results of the women enrolled in these TAXUS trials and compared them with the corresponding endpoints in men.

Of the 3,445 patients enrolled in the TAXUS trials between June 2001 and March 2004, 955 (27.7%) were women. Of these women, 480 received PES and 475 received BMS. Of the 2,490 men enrolled, 1,238 received PES and 1,252 received BMS. As compared to men, women were older (mean age 65.4 +/- 10.9 years versus 61.0 +/- 10.4 years), had smaller body surface area (1.80 +/- 0.19m2 versus 2.05 +/- 0.20m2), had more diabetes (30.4% versus 21.0%), had more hypertension (78.0% versus 65.1%), had smaller vessels (pre-procedure reference vessel diameter 2.63 +/- 0.46mm versus 2.78 +/- 0.52mm), and had more history of coronary artery disease (62.2% versus 54.7%) (p for all <0.001). There were no other significant differences in baseline demographics, lesion or procedural characteristics between the PES and BMS groups in both genders.

Results show that the TAXUS Stent maintained its advantage in preventing repeat procedures compared to the bare-metal stent control, while showing no significant differences in outcomes based on gender. At one year, the unadjusted rate of target lesion revascularization (TLR) in the PES-treated group was 8.1 percent in women versus 6.7 percent in men (p=0.297), while in the BMS-treated group, the unadjusted TLR rate at one year was 17.5 percent in women versus 16.4 percent in men (p=0.613). At three years, the data showed continued low TLR rates in both women and men treated with PES (10.7% in women versus 8.8% in men, with no difference between men and women, p=0.301).

Comparable results in safety outcomes were seen for women, showing no differences in major adverse cardiac event (MACE) rates at one year. MACE rates in the PES grou
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
2. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
3. SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus Drug-Eluting Coronary Stent Systems
4. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
5. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
6. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
7. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
8. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 "Whether it,s our family, ... day." In a single sentence, Dr. ... officer at Pfizer,s Centers for Therapeutic Innovation ... fueling progress at America,s biopharmaceutical companies. ... with academia, patient foundations and the National Institutes of ...
(Date:3/26/2015)... 26, 2015 When they began experiencing ... PACS vendor their system would no longer be ... needed a better structured solution to support their ... due to its interface capabilities and its 2014 ... through to the hospital,s radiology department. Avreo,s experienced ...
(Date:3/26/2015)... 26, 2015 Zimmer Holdings, Inc. (NYSE and ... Advanced Bearing Technology with Vitamin E by celebrating ... earlier this month reported that, at 96 million cycles ... Bearing Technology featuring Vitamin E grafted highly crosslinked polyethylene ... rate reduction of 95 percent, with no cracking, delamination ...
Breaking Medicine Technology:Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
... Ferring Pharmaceuticals Inc. today announced publication of one ... (tranexamic acid) tablets for cyclic heavy menstrual bleeding ... journal, Obstetrics & Gynecology .  The six-month ... blood loss from baseline, and improved health-related quality-of-life ...
... Oct. 6 AstraZeneca (NYSE: AZN ... at no cost to qualifying patients at the ... (Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) ... is an expansion of its AZ&Me™ Prescription Savings ...
Cached Medicine Technology:Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 2Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 3Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study 4AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients 2AstraZeneca and the Sacramento County Pharmacy Provide Free Medicines to Eligible California Patients 3
(Date:3/26/2015)... March 26, 2015 Dr. Rod ... annual Dallas Rhinoplasty Symposium and has trained over ... the importance of evidence based medicine (EBM), that is, ... well conducted research. , "We often hear from ... and while we are certainly not trying to stifle ...
(Date:3/26/2015)... North American Seminars launches it new mobile website ... information regarding OT PT continuing education courses to the ... leader in live hands PT continuing education courses ... online continuing education courses. , Featured Live ... Clinicians Approach to Advanced Concepts in Examination and Treatment ...
(Date:3/26/2015)... 2015 The American College of Traditional Chinese ... topics of the DAOM Program as well as Marketing Basics ... will be hosted by Dr. Carla Wilson, who will give ... on how to prepare for the spring quarter. The webinar ... 27, April 1 and April 3. Attendees can log in ...
(Date:3/26/2015)... Doctors Scott Sullivan and Frank DellaCroce, Co-Founders of the ... the St. Charles Surgical Hospital (SCSH) in ... Surgical Oncologist Dr. William Karl Ordoyne has joined their ... surgical oncologist Alan Stolier, M.D., FACS and the team ... Sullivan, M.D., FACS; Chris Trahan, M.D., FACS; M. Whitten ...
(Date:3/26/2015)... Doylestown, PA (PRWEB) March 26, 2015 ... recruited a new team of nationally renowned scientists to ... hepatitis B, a move that nearly triples its research ... scientists focusing solely on hepatitis B and liver cancer ... Drs. Timothy Block, Jinhong Chang, Ju Tao Guo and ...
Breaking Medicine News(10 mins):Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 2Health News:North American Seminars Launches Healthclick.com, a New Mobile Ready Website, Providing CME Course Information to PT, PTA, OT and ATC's 3Health News:ACTCM Announces Upcoming Webinars 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 2Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 3Health News:Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists 4
... study published in the Lancet has revealed how British American ... strategy to mask the toxicity of the manufactured cigarettes. // ... of the company by Canadian researchers, it has been found ... nicotine under real life situations, while in documentation, it was ...
... at the University of Iowa Roy J. and Lucille A. ... (PET) technology can help // doctors gauge the response of ... and co-author Bruce Cheson, M.D., of the Lombardi Comprehensive Cancer ... usage of PET n gauging the response of the tumor ...
... service policy acceptance in schools it has been found ... directors' perceptions. // ,They have different ideas ... among key stakeholders addressing new wellness policy development mandated ... 2004. ,'Competitive foods are those sold ...
... respiratory illness as a result of breast-feeding, according to a ... belonging to the age group of 6 years to 24 ... They identified five groups, formula-fed only, full breastfeeding for ... months, full breastfeeding from four to less than six months, ...
... the wrong reasons. Blaming the government of apathy over the ... post of Chief Scientific Officer at the Department of Health, has ... vaccine adequately, despite a lurking fear of autism, as a probable ... it could turn out to be the worst disgrace in medical ...
... Health Grade, a health ratings company, the top 5 % ... to lower the risk of death to patients by ... risk of complications. //,Health Grades, as part of their ... in the United States. ,Death and complication rates for ...
Cached Medicine News:Health News:Clash of Difference of perceptions in food policy among Principals’ and Director 2
... One of the most innovative and ... Thermotherapy (WIT) provides an ideal solution for ... office. No other option provides a better ... The AquaTherm System heats, circulates, and maintains ...
... generally confirmed by a positive heterophil antibody test ... not indicated by the heterophil antibody test. ... percent of children. Detection and identification of ... the stage of EBV infection. Bio-Rad offers ...
... Every Bard® Biopsy Instrument and Needle is ... important goal: a large quality, reliable core ... performance, featuring ultra-sharp tips and polished surfaces ... selection of biopsy systems and needle sizes ...
... Used to obtain multiple core biopsies ... Quick-Core® Biopsy Needle design facilitates one-handed control. ... tissue sample. Beveled point stylet permits easy ... to surrounding tissue. Sharp cutting edge of ...
Medicine Products: